Indication
Details coming soon
Details coming soon
| Clinical Information | Administration Information |
|---|---|
|
Indication: Allergic rhinitis Age: Adult |
Dose: Nasal spray – 2 sprays (55 mcg) into each nostril Frequency: once daily Note: may reduce to 1 spray (27.5 mcg) into each nostril once daily if symptoms are controlled |
| Clinical Information | Administration Information |
|---|---|
|
Indication: Allergic rhinitis (Seasonal/Perennial) Age: 2-11 years |
Dose: Nasal spray – 1 spray in each nostril Frequency: once daily Note: may be increased to 2 sprays (55 micrograms) into each nostril once daily if necessary |
| Drug Name | Risk Factors |
|---|---|
|
CYP3A4 inhibitors (e.g. ritonavir)
|
May lead to increased plasma concentrations
|
| Disease Name | Risk Factors |
|---|---|
|
No specific contraindications listed
|
Monitor for general drug reactions
|
Clinical & regulatory information on this page is compiled from the following government sources:
DISCLAIMER: This drug information content is provided for informational purposes only and is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Patients should always consult their physician with any questions regarding a medical condition and to obtain medical advice and treatment.